Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Parkinson's study tests Brain-Boosting exercises to improve daily life

NCT ID NCT07611578

Knowledge-focused Sponsor: Alvaro Reyes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether dual-task training—doing two things at once, like walking while solving a puzzle—can improve self-efficacy (confidence) and physical function in people with Parkinson's disease. Researchers will compare different training types (motor-cognitive vs motor-motor) and attention strategies (fixed vs variable priority) over 8 weeks in 112 participants. The goal is to find the best rehab approach to help people with Parkinson's stay active and independent.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dual-task training (motor-cognitive or motor-motor exercises with fixed or variable attention focus)
What this could lead to
If successful, this could point toward personalized rehabilitation strategies that boost confidence and daily function in people with Parkinson's.
What could go wrong
This is an early-stage study (not yet recruiting) with 112 participants, so results may not apply broadly. It tests training effects, not a drug or cure, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 112 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participants diagnosed with idiopathic Parkinson's disease confirmed by a neurologist will be recruited in this study. Inclusion criteria will be: 1. Hoehn \& Yahr stages I, II or III 2. Participants with no or mild to moderate neurocognitive impairments 3. Participants with and without symptoms of depression 4. Able to walk independently 5. Unaltered dose and type of medication up to three months before the commencement of the study 6. Participants able to understand and respond to the instructions given in the study. Exclusion criteria will be: 1. The presence of any other concomitant neurological, musculoskeletal disease 2. History of leg or brain trauma or surgery 3. Vision or hearing problems that may affect the performance of cognitive tests 4. Clinical diagnosis of major neurocognitive disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson's disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson's disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Campus Casona de Las Condes

    Santiago, Las Condes, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.